Cerebrolysin vs Dihexa
Side-by-side comparison of Cerebrolysin, Dihexa — mechanism, dosing, half-life, side effects, and research status.
| Attribute | Cerebrolysin Cerebrolysin (Porcine Brain-Derived Neuropeptide Mixture) Cognitive | Dihexa Dihexa (PNB-0408) Cognitive |
|---|---|---|
| Basics | ||
| Molecular type | Neuropeptide Mixture | HGF/MET Potentiator |
| Amino acids | — | — |
| Molecular weight | — | 413.5 Da |
| Half-life | Short (hours) | Long-acting (days) |
| Route(s) | Intravenous (IV), Intramuscular | Oral, Transdermal, Subcutaneous (research) |
| Mechanism & Research | ||
| Primary mechanism | Cerebrolysin's mechanism is attributed to its low-molecular-weight peptide fraction, which crosses the blood-brain barrier and exerts BDNF-like, NGF-like, and VEGF-like neurotrophic effects. It stimulates neuroplasticity… | Dihexa binds to and potentiates the HGF/MET signalling axis. HGF-MET signalling drives synaptogenesis — the formation of new neural connections. By dramatically amplifying this pathway, Dihexa promotes dendritic spine de… |
| Research status | Research Compound | Research Compound |
| Evidence summary | Cerebrolysin has one of the most extensive clinical research programmes of any nootropic compound, with over 100 controlled trials across Alzheimer's disease, stroke, TBI, and vascular dementia. Evidence is mixed across … | Dihexa research is primarily from Washington State University's McCoy group. Dramatic findings in animal models have generated interest, but human clinical trials are not yet published. Anecdotal reports from users are b… |
| Protocol & Dosing | ||
| Typical dose | 10–30 mL per session (IV); 5–10 mL IM | 10–15 mg/day (oral or transdermal) |
| Frequency | Daily for 10–20 day courses | Daily or 5 days on / 2 days off |
| Duration | 10–20 day IV course, repeated quarterly | 4–8 weeks |
| Timing | Morning | Morning |
| Safety | ||
| Common side effects |
|
|
| Contraindications |
|
|
| Anti-doping | Not Prohibited | Not Prohibited |
| Deeper reading | ||
| Related peptides | Semax, Dihexa, Selank | Semax, Selank, P21 |
| Full profile | Read full Cerebrolysin profile → | Read full Dihexa profile → |
Comparison data is compiled from each peptide’s individual profile. All values are drawn from peer-reviewed research and regulatory sources. For educational use only — not medical advice. Verify any protocol with a qualified healthcare provider.